大豆分離蛋白介入對高BMI受試者之體重、體脂肪和血脂肪之研究

Study on the regulation of high BMI subjects’ weight and body fat and blood lipids by soy protein isolate

黃愛玲(Ai-Ling Huang)

指導教授 ： 王進崑

中山醫學大學/健康管理學院/營養學研究所/碩士(2014年)

https://doi.org/10.6834/CSMU.2014.00125

摘要

本研究將大豆分離蛋白介入減重計畫中，和一般營養減重計畫作比較。兩組分別進行12週，每週進行體位測量，並於實驗前後抽血檢測相關血液生化值。
本研究分為一般減重組和實驗減重組.每組15人，為期12週。最主要之差異為蛋白質來源。一般組的蛋白質來源為動植物之食物(食品)蛋白質，實驗組則需每日介入40公克之大豆分離蛋白。
結果顯示，一般組與實驗組在體重、身體質量指數、體脂肪率、在介入後12週後均有顯著降低（p<0.01）。實驗組之血壓、血清總膽固醇、三酸甘油酯、肝功能指數都低於一般組 (p＜0.05)，兩組在介入12週後，尿酸以及血糖沒有顯著變化。由實驗結果顯示，介入大豆分離蛋白的減重飲食相較於一般傳統減重飲食之介入效果更好。

關鍵字

大豆分離蛋白

並列摘要

The purpose of this study was to investigate whether the intervention of soy protein isolate is more effective on the weight management than normal diet. The subjects were divided into two groups : (1) the control group (n=15) which consumed normal protein diet and (2) the experiment group (n=15) which consumed 40g soy protein isolate every day. The experimental period was 12 weeks. After 12 weeks of intervention, the body weight, BMI,and body fat were significantly decreased in both groups（p<0.01）.
Blood pressure, serum cholesterol, TG, GOT and GPT were significantly decreased（p<0.05）in the experimental group as
compared with the control group. Serum uric acid and glucose were not changed.
In conclusion, soy protein isolate intervention was more effective than normal diet intervention on the management of body weight.

並列關鍵字

soy protein isolate

參考文獻

彭仁奎、黃國晉、陳慶餘(2006)。肥胖與代謝症候群。

Allison DB, Gadbury G, Schwartz LG, Murugesan R, Kraker JL, Heshka S, Fontaine KR & Heymsfield SB. (2003) A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Eur. J Clin. Nutr. 57: 514−522.

Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276282.

Anderson JW, Smith BM, Washnock CS (1999) Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr 70: 464S-474S.

Castelli WP, Garrison RJ, Wilson PWF (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham study. JAMA 256:2835- 2838.